The Company
Our Services
Early Drug Development
Pre Clinical
Clinical
BioProduction
Diagnostics
Case Studies
Blog
Get in Touch
Sitemap
Pages
Home
The Company
Our Services
Early Drug Development
Pre Clinical
Clinical
Bio Production
Diagnostics
Case Studies
News & Insights
Blog
Contact Us
Posts
In Vitro
ADME Studies: Laying the Foundation for Preclinical Success
Achieving The FDA Requirements Related To Going From Method Development Through Validation, And Doing It Cost Effectively
Bioanalytical Method Development: Best Practices for Regulatory Compliant Data
Biotech Innovator InfinixBio Welcomes Jennifer Logan as New Chief Marketing Officer to Drive Business Development and Strategic Growth
Celebrating a New Milestone in Alzheimer’s Research
Defining the Process of Assay Development and Validation
First-in-Human Dosing: CRO Support for a Seamless Phase 1 Transition
From Concept to Reality: The Journey of Assay Development and Validation with InfinixBio
From Hit-to-Lead: How CRO Partnerships Accelerate Drug Discovery Timelines
How a leading biotechnology company partnered with InfinixBio to engineer and deliver usable strains for their line of custom therapeutic antibodies.
How Bacteria Develop Resistance to Drugs?
How Is Gene Therapy Being Used for Disease Treatment?
How to Ensure Data Integrity in Preclinical Studies: A Guide for Sponsors
How To Establish Bio Analysis And Animal Studies And Bridge Them To The Clinical Study
How To Meet The Regulatory Requirements For Preclinical Assay Development
InfinixBio & NCH Partner on TSC Therapeutic
InfinixBio Announces New Pharmacokinetics Division
InfinixBio Appoints Craig McElroy, Ph.D., as Vice President of Pharmacokinetics Division
InfinixBio To Present Breakthrough Anticancer Technology at The AACR Annual Meeting, Sunday, April 16, 2023, In Orlando, Florida
Phase 1 vs. Phase 2 Trials: CRO Support Across Clinical Milestones
Small Molecule Optimization in the Preclinical Phase: Accelerating the Path to Clinical Success
Structure and Function of a Dual Antagonist of the Human Growth Hormone and Prolactin Receptors with Site-specific PEG Conjugates: A Revolutionary Development
Supporting Threat Agent Science: The CRO Advantage in Medical Countermeasure (MCM) Development
Target Identification vs. Target Validation: What’s the Difference in Early Drug Discovery?
The Future of Gene Therapy Immunogenicity Assessment
The Role of InfinixBio in Accelerating Pre-Clinical Research
Unlocking Innovation: Custom Genetic Engineering Services for Biotech Companies
What Are IND-Enabling Studies and Why Are They Critical to Drug Development?
What Are the Challenges in Analyzing Biospecific Anti-Drug Antibodies?
What Are the Stages of Drug Development?
What Is CMC In Drug Development
Why Are Patents Important to Drug Development?
Why The Company Conducting Your Animal Studies Is Not The Best Choice To Do The Assay Development Through Assay Validation
Case Studies
Advancing Cancer Immunotherapy with InfinixBio
Driving Innovations in STING Technology for Cancer Immunotherapy
How a leading biotechnology company partnered with InfinixBio to engineer and deliver usable strains for their line of custom therapeutic antibodies
Novel antibiotic susceptibility testing that is robust, reliable, and rapid
Novel Platform Technology Made a Reality Through InfinixBio’s Rapid Development
Optimizing Dendritic Cell Cancer Vaccine Efficacy with InfinixBio
Successful Proprietary Drug Development Company turns to InfinixBio for Pre-clinical All-In-One Studies and Bioanalysis
